Based in Cohasset, John Mullaly is a private investor with a focus on the life sciences sector, drawing on experience in institutional research sales and the equity capital markets. John Mullaly of Cohasset applies a bottom-up research approach and concentrates on later-stage scientific innovation that addresses unmet needs. He maintains long-standing industry relationships built over more than two decades.
Throughout his career, John Steven Mullaly has served as a healthcare specialist within investment banking environments, where he supports investment bankers, trading desks, and research sales teams with sector-specific information. He has also advised small and mid-cap biotechnology companies on investor relations, and assisted with financing activities and capital-market communication. Before entering the industry, he earned an MBA from the Questrom School of Business and a BA in economics from Northeastern University.
Today, as a self-employed private investor, John Steven Mullaly evaluates opportunities across drug development, cell therapy, gene therapy, gene editing, small molecules, biologics, RNA therapies, antivirals, antimicrobials, and therapeutic areas including oncology, immunology, neurology, dermatology, ophthalmology, and genetic disease. Outside of work, he enjoys uphill skiing, skiing, running, and mountain biking.